- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-25
DOI
10.3389/fphar.2020.00063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term safety and efficacy of cannabidiol in children and adults with treatment-resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results
- (2019) Linda C. Laux et al. EPILEPSY RESEARCH
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
- (2019) Serena Silvestro et al. MOLECULES
- Contrasting Roles of Cannabidiol as an Insecticide and Rescuing Agent for Ethanol–induced Death in the Tobacco Hornworm Manduca sexta
- (2019) Sang-Hyuck Park et al. Scientific Reports
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis
- (2018) Peter M Irving et al. INFLAMMATORY BOWEL DISEASES
- Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis
- (2018) B. M. Fonseca et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
- (2018) Gustavo Gonzalez-Cuevas et al. NEUROPSYCHOPHARMACOLOGY
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
- (2018) Tibor Stark et al. NEUROPHARMACOLOGY
- A Review of the Therapeutic Antitumor Potential of Cannabinoids
- (2017) Višnja Bogdanović et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
- (2017) Carina Hasenoehrl et al. Expert Review of Gastroenterology & Hepatology
- Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
- (2017) Daniela Vergara et al. Scientific Reports
- Cannabis sativa: The Plant of the Thousand and One Molecules
- (2016) Christelle M. Andre et al. Frontiers in Plant Science
- DSM-5 cannabis use disorder: A phenotypic and genomic perspective
- (2013) Arpana Agrawal et al. DRUG AND ALCOHOL DEPENDENCE
- Endocannabinoid system and mood disorders: Priming a target for new therapies
- (2012) Vincenzo Micale et al. PHARMACOLOGY & THERAPEUTICS
- Regulation of nausea and vomiting by cannabinoids
- (2010) Linda A Parker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes
- (2010) Justin Thomas Fischedick et al. PHYTOCHEMISTRY
- Biologically Active Cannabinoids from High-PotencyCannabis sativa
- (2009) Mohamed M. Radwan et al. JOURNAL OF NATURAL PRODUCTS
- Cannabidiol for the treatment of psychosis in Parkinson’s disease
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
- (2008) Antonio Waldo Zuardi REVISTA BRASILEIRA DE PSIQUIATRIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now